Annika E Michelsen Selected Research

Annika E Michelsen Research Topics

Disease

30	Inflammation (Inflammations) 04/2024 - 11/2008
11	Myocardial Infarction 06/2024 - 01/2008
9	Acute Coronary Syndrome 10/2021 - 10/2017
9	Atherosclerosis 10/2020 - 08/2010
7	COVID-19 05/2024 - 01/2021
6	Carotid Artery Diseases 01/2020 - 08/2010
5	Non-ST Elevated Myocardial Infarction 05/2023 - 08/2016
5	Infections 12/2022 - 02/2020
5	Stroke (Strokes) 06/2020 - 12/2018
5	Atherosclerotic Plaque (Atheroma) 08/2016 - 12/2007
4	Type 2 Diabetes Mellitus (MODY) 04/2024 - 10/2016
4	Pneumonia (Pneumonitis) 01/2023 - 02/2019
4	Insulin Resistance 08/2022 - 10/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2020
4	Heart Failure 01/2021 - 01/2017
3	Respiratory Insufficiency (Respiratory Failure) 01/2024 - 01/2021
3	Fibrosis (Cirrhosis) 03/2023 - 01/2017
3	Malaria 10/2021 - 12/2018
3	Coinfection 10/2021 - 01/2020
3	HIV Infections (HIV Infection) 11/2020 - 08/2015
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2019 - 11/2017
3	Relapsing-Remitting Multiple Sclerosis 12/2015 - 06/2014
3	Multiple Sclerosis 11/2015 - 01/2013
3	Carotid Stenosis (Carotid Artery Stenosis) 03/2015 - 12/2007
2	Chest Pain (Chest Pains) 06/2024 - 10/2021
2	Prediabetic State (Prediabetes) 04/2024 - 01/2020
2	Pre-Eclampsia (Preeclampsia) 11/2023 - 11/2017
2	Coronary Disease (Coronary Heart Disease) 05/2023 - 12/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2023 - 12/2018
2	Heart Arrest (Cardiac Arrest) 01/2023 - 01/2022
2	ST Elevation Myocardial Infarction 06/2022 - 01/2020
2	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2021 - 01/2020
2	Parasitemia 10/2021 - 01/2020
2	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2021
2	Thrombosis (Thrombus) 10/2021 - 01/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 10/2020 - 10/2019
2	Necrosis 10/2019 - 05/2010
2	Disease Progression 03/2015 - 01/2015
2	Ischemic Stroke 01/2014 - 01/2011

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2013
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2010
8	Interleukin-6 (Interleukin 6)IBA 01/2023 - 08/2016
7	Troponin T (Troponin T1)IBA 06/2024 - 08/2016
7	ChemokinesIBA 06/2024 - 05/2010
7	CytokinesIBA 01/2022 - 01/2014
7	Messenger RNA (mRNA)IBA 11/2017 - 05/2010
6	C-Reactive ProteinIBA 10/2021 - 01/2016
6	LipidsIBA 01/2018 - 11/2008
5	LigandsIBA 06/2024 - 04/2014
5	Lipopolysaccharide ReceptorsIBA 04/2024 - 09/2017
5	tocilizumab (atlizumab)FDA Link 06/2022 - 08/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2013
4	Trinitrotoluene (TNT)IBA 06/2024 - 08/2016
4	EnzymesIBA 04/2024 - 08/2010
4	IronIBA 01/2023 - 01/2018
4	InterleukinsIBA 06/2022 - 03/2015
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2019
4	Vitamin D FDA LinkGeneric 01/2020 - 01/2015
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019 - 08/2016
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 01/2014
3	Insulin (Novolin)FDA Link 03/2023 - 11/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 03/2023 - 01/2013
3	HepcidinsIBA 01/2023 - 04/2021
3	Interleukin-12 (IL 12)IBA 01/2023 - 03/2015
3	Complement System Proteins (Complement)IBA 01/2022 - 01/2017
3	VaccinesIBA 01/2022 - 01/2021
3	Transferrin (beta 2 Transferrin)IBA 01/2022 - 01/2018
3	Ferritins (Ferritin)IBA 01/2022 - 01/2018
3	Growth Differentiation Factor 15IBA 01/2022 - 01/2019
3	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 01/2017
3	AdipokinesIBA 01/2019 - 10/2013
2	Triglycerides (Triacylglycerol)IBA 04/2024 - 01/2023
2	MucinsIBA 04/2024 - 02/2020
2	ImmunosorbentsIBA 04/2024 - 02/2020
2	Immunoglobulins (Immunoglobulin)IBA 04/2024 - 02/2020
2	Peroxidase (Myeloperoxidase)IBA 04/2024 - 01/2021
2	Hormones (Hormone)IBA 04/2024 - 01/2023
2	von Willebrand FactorIBA 05/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 03/2023 - 06/2022
2	Lipoproteins (Lipoprotein)IBA 01/2023 - 11/2017
2	LipopolysaccharidesIBA 01/2023 - 04/2022
2	Fatty Acid-Binding ProteinsIBA 01/2023 - 01/2011
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2022 - 04/2021
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 05/2010
2	AntibodiesIBA 01/2022 - 01/2022
2	Interleukin-27 (Interleukin 27)IBA 10/2021 - 01/2020
2	ChAdOx1 nCoV-19IBA 10/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 10/2021 - 01/2016
2	asparaginylendopeptidase (legumain)IBA 01/2020 - 01/2020
2	Cysteine Proteases (Cysteine Protease)IBA 01/2020 - 01/2020
2	Chemokine CXCL16IBA 11/2019 - 11/2017
2	Scavenger Receptors (Scavenger Receptor)IBA 11/2019 - 11/2008
2	oxidized low density lipoproteinIBA 11/2019 - 01/2014
2	hydroxide ionIBA 12/2015 - 01/2015
2	Cholecalciferol (Vitamin D3)FDA Link 12/2015 - 01/2015
2	Chemokine CXCL13IBA 06/2014 - 09/2012
1	Interleukin-22 (IL-22)IBA 05/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2024

Therapy/Procedure

5	Therapeutics 10/2021 - 03/2015
2	Art Therapy 02/2020 - 08/2015